Taysha Gene Therapies, Inc. (TSHA)
NASDAQ·Healthcare·Biotechnology
$5.02
-2.81%
Mkt Cap $1.79B
Analyst Ratings
Buy
9
Hold
0
Sell
0
Price Target (18 analysts)
$14.00
Range $13.00 – $15.00
Implied Upside
+179.2%
Consensus $14.00 vs current $5.02
NASDAQ·Healthcare·Biotechnology
$5.02
-2.81%
Mkt Cap $1.79B
Buy
9
Hold
0
Sell
0
Price Target (18 analysts)
$14.00
Range $13.00 – $15.00
+179.2%
Consensus $14.00 vs current $5.02